Expression and significance of microRNAs in the p53 pathway in ovarian cancer cells and serous ovarian cancer tissues

Chinese Journal of Oncology

Volumn 33, Issue 12, 2011, Pages 885-890

  Zhang, Qi ^a   He, Xiang Jun ^b   Ma, Li Ping ^b   Li, Na ^b   Yang, Jing ^b   Cheng, Ye Xia ^b   Cui, Heng ^b  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b NONE

Author keywords

MicroRNA; Ovarian neoplasms; P53 pathway

Indexed keywords

DOXORUBICIN; MICRORNA; MICRORNA 192; MICRORNA 194; MICRORNA 34A; MICRORNA 34B; MICRORNA 34C; MICRORNA 449A; MICRORNA 449B; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER STAGING; CELL CYCLE; CELL CYCLE ARREST; HUMAN; HUMAN CELL; HUMAN TISSUE; OVARY CANCER; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UTERINE TUBE; WESTERN BLOTTING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; CELL CYCLE; CELL LINE, TUMOR; CYSTADENOCARCINOMA, SEROUS; DOXORUBICIN; FEMALE; HUMANS; MICRORNAS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; OVARIAN NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84862958666     PISSN: 02533766     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0253-3766.2011.12.002     Document Type: Article

References (23)

1. Karst AM, Drapkin R. Ovarian cancer pathogenesis: a model in evolution. J Oncol, 2010, 2010:932371.
2. Kurman RJ, Shih IeM. Pathogenesis of ovarian cancer; lessons from morphology and molecular biology and their clinical implications. Int J Gynecol Pathol, 2008, 27:151-160. (Pubitemid 351450677)
3. Tang G, Tang X, Mendu V, et al. The art of microRNA; various strategies leading to gene silencing via an ancient pathway. Biochim Biophys Acta, 2008, 1779:655-662.
4. Bommer GT, Gerin I, Feng Y, et al. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol, 2007, 17:1298-1307. (Pubitemid 47176893)
5. He L, He X, Lim LP, et al. A microRNA component of the p53 tumour suppressor network. Nature, 2007, 447:1130-1134. (Pubitemid 47014436)
6. He X, He L, Hannon GJ. The Guardian's little helper; microRNAs in the p53 tumor suppressor network. Cancer Res, 2007, 67:11099-11101.
7. Corney DC, Flesken-Nikitin A, Godwin AK, et al. MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res, 2007, 67:8433-8438. (Pubitemid 47437414)
8. Tarasov V, Jung P, Verdoodt B, et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle, 2007, 6:1586-1593. (Pubitemid 47327945)
9. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell, 2007, 26:731-743. (Pubitemid 46856247)
10. Liang Y, Ridzon D, Wong L, et al. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics, 2007, 8:166.
11. Georges SA, Biery MC, Kim SY, et al. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215. Cancer Res, 2008, 68:10105-10112.
12. Braun CJ, Zhang X, Savelyeva I, et al. p53-Responsive micromas 192 and 215 are capable of inducing cell cycle arrest. Cancer Res, 2008, 68:10094-10104.
13. Andersen CL, Jensen JL, Omtoft TF. Normalization of real-time quantitative reverse transcription-PCR data : a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets. Cancer Res, 2004, 64:5245-5250. (Pubitemid 39006544)
14. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA, 2008, 14:844-852. (Pubitemid 351574906)
15. Vandesompele J, De Preter K, Pattyn F, et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol, 2002, 3:research0034.
16. Zhang L, Volinia S, Bonome T, et al. Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci USA, 2008, 105:7004-7009. (Pubitemid 351754520)
17. Corney DC, Hwang CI, Matoso A, et al. Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res, 2010, 16:1119-1128.
18. Lee CH, Subramanian S, Beck AH, et al. MicroRNA profiling of BRCA1/2 mutation-carrying and non-mutation-carrying high-grade serous carcinomas of ovary. PLoS One, 2009, 4:e7314.
19. Rokhlin OW, Scheinker VS, Taghiyev AF, et al. MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer. Cancer Biol Ther, 2008, 7:1288-1296.
20. Ahmed AA, Etemadmoghadam D, Temple J, et al. Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary. J Pathol, 2010, 221:49-56.
21. Dubeau L. The cell of origin of ovarian epithelial tumours. Lancet Oncol, 2008, 9:1191-1197.